Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × Colony-Stimulating Factors × Clear all

NCT00064129 2020-07-30

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms